We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Ezetimibe
Australian Public Assessment Report
Device/Product Name
Ezetrol
Active ingredients
Ezetimibe
AusPAR Date
Published
Submission Number
PM-2011-01220-3-3
Submission Type
Extension of indications
Decision
Proposed Extension of Indication withdrawn. Revisions to Product Information, including to Dosage and Administration and Clinical Trials sections approved